
Ben Uglow
Ben Uglow is the founder of Oxcap Analytics, an independent research firm based in London, specializing in capital goods. He has a long-standing background in financial analysis, having previously served as the head of European Capital Goods Research at Morgan Stanley for two decades. Uglow is recognized for his extensive knowledge of Siemens and has been vocal about the company's strategies regarding its Healthineers division, particularly in light of recent speculation regarding potential divestments.
Not in the pool (under ¢1).
Recent news mentions
Ben Uglow from Oxcap Analytics commented on ABB's performance, calling it 'a real monster'.
Börsenkommentar zu Swatch Group, ABB, Swissquote und SilberBen Uglow is the founder of Oxcap Analytics and previously the Head of European Capital Goods Research at Morgan Stanley.
Schneider Electric gehört auf die KauflisteBen Uglow, founder of Oxcap Analytics, stated that many investors are betting on Siemens significantly reducing its stake in Healthineers.
keine Trennung von Healthineers 2025














